The People Who Brought You Cheaper Hepatitis C Drugs Are Going After Cancer Next

Express Scripts, which this year forced price concessions from makers of $1,000-a-day hepatitis C medicines, has set its sights on $37 billion in U.S. spending on cancer medications. Its goal is to start influencing the drugs’ costs as soon as next year.

[button title=”Read More” link=”http://www.bloomberg.com/news/2015-01-22/express-scripts-targets-150-000-cancer-drug-prices-in-2016-plan.html” target=”_blank” size=”” color=”” class=””]